Herbalife Nutrition Ltd.

Herbalife Nutrition Ltd. (HLF) Market Cap

Herbalife Nutrition Ltd. has a market capitalization of $1.18B.

Price: $11.43

0.04 (0.35%)

Market Cap: 1.18B

NYSE · time unavailable

CEO: Stephan Paulo Gratziani

Sector: Consumer Defensive

Industry: Packaged Foods

IPO Date: 2004-12-16

Website: https://www.herbalife.com

Herbalife Nutrition Ltd. (HLF) - Company Information

Market Cap: 1.18B|Sector: Consumer Defensive

Company Profile

Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Analyst Sentiment

77%
Strong Buy

From 4 Active Polls

1Y Forecast: $18.50

▲ +61.9% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$19

High Bound

$20

Average

$19

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$18.50
▲ +61.85% Upside
Low Target
$17.00
49% Risk
Median Target
$18.50
62% Mid
High Target
$20.00
75% Max
Consensus
Buy
14 / 26 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,1851,5281,3258728858766767251,040
Enterprise Value ($M)8981,2413,3112,7752,9102,9472,7302,7943,220
Price to Earnings Ratio (P/E)4.956.173.885.054.494.340.953.8355.33
Price/Earnings-to-Growth Ratio (PEG)2.325.314.351.473.6741.64
Price to Sales Ratio (P/S)0.231.161.030.680.700.720.560.580.81
Price to Book Ratio (P/B)-2.69-3.46-2.57-1.42-1.34-1.19-0.84-0.76-1.00
Price to Free Cash Flow Ratio (P/FCF)3.1714.8516.617.3912.09-48.3915.4110.0215.71
Enterprise Value to Sales (EV/Sales)0.942.582.182.312.412.262.252.51
Enterprise Value to EBITDA (EV/EBITDA)1.517.5631.3317.5117.6518.8819.7117.4030.60
Debt to Equity Ratio-0.48-0.37-4.54-3.62-3.55-3.26-3.08-2.59-2.46

HLF Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$11.43
Intrinsic Value$58.87
Market Alignment
Undervalued by 415.0%relative to calculated intrinsic value
9.00%
Exp: 0%0%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.45B
Perpetuity TV Value$8.39B
Discounted TV (PV)$3.54B
TV Weighting %57.5%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HERBALIFE LTD (HLF) — Investment Overview

🧩 Business Model Overview

Herbalife operates in the global nutrition and weight-management category through an independent distributor network rather than a traditional wholesale/retail model. The value chain runs from the company’s manufacturing and sourcing operations to an inventory system sold primarily to independent distributors, who then market and resell products to end customers and earn commissions based on personal sales and downline activity. This structure creates “repeat behavior” at two levels: distributors maintain ongoing product inventory and customer relationships, while end consumers tend to reorder nutrition programs if they view products as part of their routine.

The model is therefore less dependent on mass media demand generation and more dependent on distributor recruitment, retention, and training—each supported by a standardized compensation and brand/education framework.

💰 Revenue Streams & Monetisation Model

Revenue is driven predominantly by product sales, with a portion of monetisation coming through distributor incentives and related programs that align distributor activity with volume. The key margin drivers are:

  • Unit economics and mix: higher-margin categories (for example, meal replacement and targeted nutrition) and favorable product mix can support gross margin.
  • Distributor demand stability: because distributors purchase inventory for resale, revenue visibility depends on distributor re-order cycles and customer replenishment.
  • Cost discipline: marketing, distribution support, and operating overhead linked to network growth influence operating leverage.

Overall, the monetisation profile is “recurring-like” in practice due to repeat consumption, even though accounting revenue is largely tied to shipment/inventory purchase events within the distributor network.

🧠 Competitive Advantages & Market Positioning

Herbalife’s competitive position is anchored in structural distribution and behavioral stickiness rather than proprietary technology.

  • Network effects (indirect): the distributor model creates a self-reinforcing sales capability. A larger active network improves local availability, peer education, and customer acquisition, which in turn can improve distributor productivity.
  • Switching costs (behavioral): customers often build routines around a preferred product set and ordering relationship. Distributors also accumulate time and know-how (training, customer base, community) that is not costless to replicate.
  • Distribution scale and execution: compared with smaller independent nutrition brands, scale supports more consistent market coverage, distributor training infrastructure, and localized go-to-market execution.

Competitive benchmarking:

  • Amway (Alticor): broader consumer product portfolio with a similar multi-level direct selling approach, typically competing on range and household penetration rather than strict focus on weight-management and meal replacement.
  • Nu Skin Enterprises: also relies on direct selling and beauty/wellness categories, competing for distributor mindshare and consumer attention using comparable network-driven recruitment.
  • DSM-Firmenich / Nestlé Health Science (CPG/health nutrition): competes through retail and institutional distribution, with switching costs driven by brand/availability and convenience rather than distributor networks.

Herbalife’s focus is concentrated on targeted nutrition and weight-management use cases, which differentiates its messaging and product mix from diversified direct sellers and from retail/CPG players that compete primarily on shelf presence and packaged brand equity.

🚀 Multi-Year Growth Drivers

  • Structural demand for weight management and everyday nutrition: increasing health awareness and chronic disease risk factors support long-run consumption of meal replacement, supplement, and targeted nutrition offerings.
  • Expansion and deeper penetration in underpenetrated markets: direct selling models can scale distribution coverage in geographies where retail execution is less efficient or where consumer purchasing behavior favors community-based selling.
  • Distributor productivity improvements: training systems, product education, and support tools can translate into higher customer conversion and improved re-order rates, reinforcing revenue durability.
  • Channel evolution: distributors can complement face-to-face sales with digital merchandising and recurring ordering behaviors, improving convenience while maintaining the network’s local credibility.

⚠ Risk Factors to Monitor

  • Regulatory and legal scrutiny of compensation practices: direct selling structures can face investigations regarding consumer protection, earnings claims, and whether incentive schemes are aligned with legitimate product sales.
  • Product/claims and public health standards: adverse regulatory actions related to health-related marketing claims or quality controls can pressure margins and increase compliance costs.
  • Network sustainability risk: distributor retention and the ability to recruit new participants are critical. Network contraction can reduce distributor purchasing and end-consumer ordering.
  • Reputational risk: litigation, regulatory headlines, or credible allegations can affect recruitment and consumer trust, with downstream effects on sales volumes.
  • Competitive pricing and promotional intensity: nutrition and wellness categories attract both direct sellers and retail brands; sustained price pressure can compress gross margin.
  • Operating and supply chain volatility: ingredient sourcing, manufacturing stability, and tariff/currency movements can influence cost structure.

📊 Valuation & Market View

Markets typically value consumer distribution businesses using EV/EBITDA and EV/Revenue frameworks, with emphasis on the durability of growth and the sustainability of margins. The key valuation sensitivities for Herbalife-like models are:

  • Regulatory risk premium: stricter enforcement or unfavorable outcomes tend to drive multiple compression due to expected margin pressure and growth uncertainty.
  • Margin trajectory: product mix and disciplined operating costs determine earnings power in distributor-based models.
  • Volume quality: investors focus on whether revenue is supported by repeat consumer demand versus accelerated distributor stocking.

🔍 Investment Takeaway

Herbalife’s long-term investment case rests on a repeat-consumption product set distributed through a large independent network. The primary moats are network effects and behavioral switching costs, supported by distribution scale and execution. The central debate for investors is not the presence of a distribution engine, but the extent to which regulatory oversight, reputational factors, and network sustainability can be managed without impairing distributor productivity and customer demand.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HLF.

businesswire.com2026-06-03

Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, has been named to three 2026 USA TODAY Most Trusted Brands lists, including Most Trusted Brands, Brands Most Trusted by Parents, and Brands Most Trusted by Senior Citizens. The recognitions reflect consumer confidence in Herbalife's science-backed products and commitment to supporting healthy, active lifestyles across generations. “Trust is foundational to our relationship wi.

fool.com2026-06-03

Chief Commercial Officer Sells 143,000 Shares of Herbalife for $1.9 Million

Known for its global nutrition products and direct-selling model, this wellness firm reported a significant insider sale in recent filings.

businesswire.com2026-06-02

Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast IDEAS Conference on Thursday, June 11, 2026 at 10:35 a.m. ET (7:35 a.m. PT). The live webcast will be available at the following link: https://event.summitcast.com/view/GAjb2PfaSPbv9ViGy3AtzN/ZC5vwyKUXDsTKS4G6iXFet A link to the webcast will also be available under the Investor Relations se.

gurufocus.com2026-05-29

A Look at Herbalife Ltd (HLF) After 4.6% Decline -- GF Value $10.01 vs Price $11.96

On May 29, 2026, Herbalife Ltd (HLF) shares fell 4.6% to a current price of $11.96, reflecting a significant drop in price performance over recent weeks. The st

seekingalpha.com2026-05-19

High Liner Foods Incorporated (HLF:CA) Shareholder/Analyst Call Prepared Remarks Transcript

High Liner Foods Incorporated (HLF:CA) Shareholder/Analyst Call Prepared Remarks Transcript

marketbeat.com2026-05-16

High Liner Foods Q1 Earnings Call Highlights

High Liner Foods TSE: HLF reported stronger first-quarter sales and volume growth for fiscal 2026, but management said profitability was pressured by higher raw material costs, elevated promotions and supply chain constraints in key whitefish species.

seekingalpha.com2026-05-14

High Liner Foods Incorporated (HLF:CA) Q1 2026 Earnings Call Transcript

High Liner Foods Incorporated (HLF:CA) Q1 2026 Earnings Call Transcript

seekingalpha.com2026-05-11

Herbalife: Impressive India Growth Can't Carry The Whole Story

Herbalife posted a Q1 revenue and EPS beat, with three consecutive quarters of volume growth, and raised full-year guidance. India's rapid expansion, now HLF's largest market, and digital wellness initiatives like Pro2col offer structural growth drivers amid regional softness. North America and China remain structurally weak, with persistent declines and regulatory headwinds offsetting emerging market gains.

seekingalpha.com2026-05-11

Herbalife: The Stock Wall Street Loves To Hate Is Making A Comeback

Herbalife is undergoing a significant transformation, shifting from its traditional multi-level marketing model to a modern health and wellness brand. HLF is leveraging biomarker-driven personalization, direct digital health engagement, and strategic acquisitions like Bioniq and Pro2col to diversify its offerings. Recent debt refinancing and ongoing reductions have improved HLF's financial profile, with debt falling from ~$3.0B in 2021 to ~$2.18B in 2025.

marketbeat.com2026-05-10

Herbalife Q1 Earnings Call Highlights

Herbalife NYSE: HLF reported first-quarter 2026 results above its prior guidance, citing continued momentum in several international markets and progress on its strategy to expand personalized nutrition offerings through technology and recent acquisitions.

seekingalpha.com2026-05-08

Herbalife Ltd. (HLF) Q1 2026 Earnings Call Transcript

Herbalife Ltd. (HLF) Q1 2026 Earnings Call Transcript

businesswire.com2026-05-08

Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with “Fuel Like Ronaldo” Campaign

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the launch of its “Fuel Like Ronaldo” campaign, a global initiative that translates elite athlete nutrition and performance strategies into practical guidance for everyday wellness seekers. Backed by more than 20 years of experience working with professional athletes, including its long-standing partnership with global sports icon Cristiano Ronaldo, Herbalife.

businesswire.com2026-05-06

Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) today reported financial results for the first quarter ended March 31, 2026: “We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation.” - Stephan Gratziani, CEO Highlights First Qua.

businesswire.com2026-04-29

Herbalife Completes $1.45 Billion Senior Secured Refinancing

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) (the “Company”), a premier health and wellness company, community and platform, today announced the closing of the previously announced private offering by HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the “Issuers”), each a wholly owned subsidiary of the Company, of $800 million aggregate principal amount of 7.750% senior secured notes due in May 2033 (“2033 Secured Notes”). Concurrently with the issuance of the 20.

gurufocus.com2026-04-16

Herbalife Ltd (HLF) Shares Fall 4.3% -- GF Value Says Still Overvalued

On April 16, 2026, Herbalife Ltd (HLF) shares fell 4.3% today, bringing the current price to $16.17. Over the past year, the stock has experienced significant v

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"HLF reported Q1 2026 results with Revenue of $1.317B and Net Income of $61.9M (EPS: $0.60 on basic; $0.57 diluted). On a YoY basis, Revenue rose from $1.222B in Q1 2025 to $1.317B in Q1 2026 (+7.9% YoY), while Net Income increased from $50.4M to $61.9M (+22.8% YoY). QoQ, Revenue edged up from $1.283B in Q4 2025 (+2.6% QoQ), but Net Income declined from $85.4M in Q4 (+27.5% QoQ decrease). Profitability was mixed: gross margin improved (77.9% vs 75.1% in Q4), but operating income swung to a small loss (-$5.5M; operating margin -0.4%) after a profitable Q4. Cash flow remained solid, with operating cash flow of $113.8M and free cash flow of $102.9M in the quarter. The balance sheet shows resilience on liquidity (cash $451M) but continued capital structure strain (negative stockholders’ equity; equity of about -$434M). Total shareholder returns were strong given price momentum (1y_change +172.8%) and no evidence of dividends; buybacks appear limited in the quarter. Analyst valuation context is broadly constructive with consensus price target around $17.33 vs the $17.02 price."

Revenue Growth

Good

Revenue +7.9% YoY (Q1 2026 vs Q1 2025) and +2.6% QoQ (Q1 vs Q4 2025), indicating steady top-line momentum.

Profitability

Fair

Net margin improved YoY (4.7% vs ~4.1%), but QoQ Net Income fell (-27.5%) and operating income deteriorated to a small operating loss in Q1 2026 (operating margin -0.4% vs +6.0% in Q4).

Cash Flow Quality

Good

Operating cash flow of $113.8M and free cash flow of $102.9M in Q1 2026 support earnings quality despite margin volatility; no dividends and no buybacks reported in this quarter.

Leverage & Balance Sheet

Caution

Liquidity improved (cash $451M), but balance sheet remains stressed with negative stockholders’ equity (~-$434M) and sizable long-term debt (~$155M) plus higher overall liabilities.

Shareholder Returns

Strong

Strong price momentum (1-year change +172.8%) provides major total return; dividend yield is 0% and buyback activity appears minimal in Q1.

Analyst Sentiment & Valuation

Positive

Consensus target ~$17.33 vs current ~$17.02 implies near-term upside is modest; valuation multiples appear sensitive given recent profitability swings.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

HLF delivered a strong Q1 2026 with net sales of $1.3b (+7.8% YoY) and adjusted EBITDA of $176m, both above the top of guidance. India drove results, posting record sales of $275m (+32% YoY) and continued momentum tied to the late-2025 GST reduction (expected tailwind through September). However, profitability still showed margin pressure: adjusted EBITDA margin fell 20 bps YoY to 13.3% despite a large 240 bps two-year improvement, with FX and absorption/sales-mix headwinds offset by pricing. The company also meaningfully improved its balance sheet via a $1.45b refinancing in April, targeting ~$45m annualized cash interest savings and setting a net leverage goal below 2.0x by year-end. Outlook remains constructive on constant-currency net sales and narrowed EBITDA ranges, but China and North America softness plus India GST-related incremental cost (~$20m–$25m; 40–50 bps) are key watch items.

AI IconGrowth Catalysts

  • India record quarterly net sales for the second consecutive quarter ($275m, +32% YoY) supported by prior late-Sep 2025 GST rate reduction
  • Distributor training and engagement momentum in India following the GST change; management expects GST tailwind through September 2026
  • Preparations for next-generation personalized supplements: Vionic integration into Protocol and rollout beginning June 2026 in 11 EMEA countries, followed by the U.S. in July

Business Development

  • Acquisition completed (April; announced March 26) of substantially all assets of Vionic core personalized nutrition business
  • Planned Vionic personalized nutritional supplements rollout: June 2026 in 11 European countries; U.S. follow in July; additional markets later in 2026
  • Protocol beta expansion to select 10 EMEA markets (from late in 2025), with an enhanced next release planned for North America Extravaganza in July

AI IconFinancial Highlights

  • Net sales: $1.3b (+7.8% YoY; +5.4% constant currency), exceeding high end of guidance (3%–7% range)
  • Adjusted EBITDA: $176m, above high end of guidance ($155m–$175m)
  • Adjusted EBITDA margin: 13.3%, down 20 bps YoY, but up 240 bps on a two-year stacked basis (including ~70 bps FX headwinds)
  • Gross margin: 77.9%, down 40 bps YoY; drivers included ~50 bps input cost inflation (lower absorption), ~30 bps unfavorable sales mix, ~20 bps other unfavorable costs, and ~50 bps FX headwinds, offset by ~70 bps pricing benefits and ~40 bps lower inventory write-downs
  • Adjusted diluted EPS: $0.64, including ~ $0.03 FX headwind; adjusted effective tax rate 27.3% vs 21.8% in 2025, ~ $0.04 unfavorable EPS impact
  • Full-year 2026 adjusted effective tax rate expected ~30%

AI IconCapital Funding

  • April refinancing completed: $1.45b senior secured refinancing including $800m 7.75% notes due May 2033, $225m Term Loan A, and $425m revolving credit facility
  • Annualized cash interest savings: approximately $45m (coupon/spread reductions: notes coupon down 450 bps; revolver spread down 300 bps; term loan spread down 375 bps to 3%)
  • Cash: $451m at quarter end (up nearly $100m vs 2025)
  • Leverage: total leverage 2.7x; net leverage 2.1x; net leverage target below 2.0x by end of 2026
  • No material maturities until 2028; revolver undrawn as of March 31 with $180m available at April 29 closing

AI IconStrategy & Ops

  • Protocol positioning: end-to-end digitization of the four core actions (“what to measure/what to take/what to do/who to do it with”) with distributors as the engagement layer
  • Protocol beta: expanded to select 10 EMEA markets; next release planned for North America Extravaganza in July including new user experience and enhanced features
  • Packaging modernization rollout began in March; substantially completed by 2027
  • Extravaganza events: initial 2026 events started in India (three consecutive events in Delhi and Bengaluru; ~46k attendees); further summer events planned across China, Eurasia, South America, Asia Pacific, Europe, and North America

AI IconMarket Outlook

  • Q2 2026 reported net sales guidance: +1.5% to +5.5% YoY; ~50 bps currency tailwind; constant currency: +1% to +5% YoY
  • Q2 2026 adjusted EBITDA guidance: $150m–$170m (reported and constant currency); includes ~ $10m YoY headwind (~80 bps margin) from (1) timing of China government grant (~$5m) and (2) India GST services mismatch creating incremental G&A (~$5m, partially offset by reduced distributor sales commission percentage)
  • Full-year 2026 reported net sales guidance: +1.5% to +5.5% YoY; constant currency: +1% to +5% YoY; FX tailwind reduced to 50 bps from 100 bps vs prior guidance
  • Full-year 2026 adjusted EBITDA guidance: $675m–$705m (narrowed ranges; constant currency midpoint increased)
  • Full-year India GST-related net incremental cost: ~$20m–$25m headwind to adjusted EBITDA; ~40–50 bps headwind to adjusted EBITDA margin
  • 2026 CapEx: $50m–$80m; capitalized SaaS implementation costs: $35m–$55m (incremental to CapEx)

AI IconRisks & Headwinds

  • Adjusted EBITDA margin compression: down 20 bps YoY despite strong top-line, driven by FX (~70 bps), lower absorption rates, and unfavorable sales mix (~30 bps)
  • India momentum relies on GST tailwind; management expects tailwind through September 2026, then moderating
  • Regional softness: North America net sales down 3% YoY due to severe weather temporary club closures and shipment/revenue deferrals; China down 12% reported YoY driven by 18% volume decline
  • Higher 2026 effective tax rate: adjusted effective tax rate 27.3% in Q1 vs 21.8% in 2025; discrete-event benefit reduced vs prior year

Q&A: Analyst Interest

  • Topic: Protocol U.S. beta behavior and distributor/customer engagement signals: Management said beta’s purpose is distributor feedback and validating fit with distributor business flows, not direct forecasting. They paused/controlled beta phases while expanding to 10 EMEA markets; enhanced release is planned for Extravaganza July. They explicitly stated no direct revenue is included in forecasts yet.
  • Topic: India GST-driven demand and whether other markets will see price-reduction programs: Management began by framing “a lesson in India,” explaining GST created momentum via an effective price decrease. The transcript cuts off before providing the remaining guidance assumptions for India constant currency for the rest of 2026 and whether similar ~30% growth is expected.

Sentiment: MIXED

Note: This summary was synthesized by AI from the HLF Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HLF.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HLF)

© 2026 Stock Market Info — Herbalife Nutrition Ltd. (HLF) Financial Profile